Both are made by the Danish drug company Novo Nordisk ... "the main driver" is the cost of the delivery device, a needle embedded in a pen, said Melissa Barber, who led the research.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Ozempic (semaglutide) is a once-weekly injectable medication that helps treat type 2 diabetes and reduces the risk of ...

Zepbound is typically sold in an injector pen, which packages the drug together with the needle used to administer ... Eli Lilly and its rival Novo Nordisk have been racing to overcome ...

Liraglutide is the first GLP-1 agonist to show benefit in this age group and could provide young patients a much-needed ...

Safety Needles Market size is estimated to soar to a notable USD 11,972.7 million by 2033 projected CAGR of 7.4%.

Novo Nordisk, maker of Ozempic and Wegovy ... paying patients who are willing to self-administer single-dose vials using a ...

The new discounted single-dose formulation will likely improve access to low doses of the weight loss drug for certain ...